A Mendelian randomization study examining the missense variants in SLC5A1, which is associated with a decrease in SGLT1 function, has shown decreased incidence of type 2 diabetes, obesity, heart failure, and death. The gene discussed is SLC5A1; the disease is type 2 diabetes mellitus.